Eye Drops Solution
Showing 1 - 25 of >10,000
Dry Eye Trial in Fort Worth (Propylene glycol solution/drops)
Not yet recruiting
- Dry Eye
- Propylene glycol solution/drops
-
Fort Worth, TexasAlcon Call Center for Trial Locations
Jun 27, 2023
Allergic Conjunctivitis, Allergic Rhinitis Trial in Vienna (Eye Drops, Solution in Single-Dose Container)
Completed
- Allergic Conjunctivitis
- Allergic Rhinitis
- Eye Drops, Solution in Single-Dose Container
-
Vienna, AustriaVienna Challenge Chamber
Aug 24, 2022
Dry Eye Trial in Fort Worth (Polyethylene glycol 400 and propylene glycol solution/drops)
Not yet recruiting
- Dry Eye
- Polyethylene glycol 400 and propylene glycol solution/drops
-
Fort Worth, TexasAlcon Call Center for Trial Locations
Jun 5, 2023
Cataract, Surgical Injury, Healing Wound Trial in Wroclaw (preservative-free solution of standard post-cataract eye drops)
Active, not recruiting
- Cataract
- +2 more
- preservative-free solution of standard post-cataract eye drops
-
Wrocław, PolandSpektrum Clinic of Ophthalmology
Feb 22, 2023
Dry Eye Trial in Fort Worth (Polyethylene glycol 400 and propylene glycol solution/drops - Preservative Free (PF), Polyethylene
Not yet recruiting
- Dry Eye
- Polyethylene glycol 400 and propylene glycol solution/drops - Preservative Free (PF)
- Polyethylene glycol 400 and propylene glycol solution/drops - Preserved
-
Fort Worth, TexasAlcon Call Center for Trial Locations
Jul 6, 2023
Presbyopia Trial (Phentolamine Opthalmic Solution 0.75%, Placebo, Low dose pilocarpine)
Not yet recruiting
- Presbyopia
- Phentolamine Opthalmic Solution 0.75%
- +3 more
- (no location specified)
Dec 2, 2022
Dry Eye Syndromes, Computer Vision Syndrome, Asthenopia Trial in Beijing (Diquafosol)
Recruiting
- Dry Eye Syndromes
- +2 more
-
Beijing, Beijing, ChinaPeking University Third Hospital
May 31, 2022
Dry Eye Syndrome Trial in United States (rhNGF 20 µg/ml, rhNGF 20 µg/ml + vehicle, Vehicle)
Completed
- Dry Eye Syndrome
- rhNGF 20 μg/ml
- +2 more
-
Glendale, California
- +11 more
Jan 13, 2022
Dry Eye Disease, Cataract Trial in Valladolid (Systane Hydration lubricant eye drops)
Recruiting
- Dry Eye Disease
- Cataract
- Systane Hydration lubricant eye drops
-
Valladolid, SpainPrincipal Investigator
Jul 11, 2022
Dry Eye Syndromes Trial in Seoul (SJP002 BID, SJP002 QID, SJP002 Placebo 1)
Completed
- Dry Eye Syndromes
- SJP002 BID
- +3 more
-
Seoul, Korea, Republic ofSeoul St. Mary's Hospital
Mar 30, 2022
Primary Open Angle Glaucoma, Ocular Hypertension Trial in Albany (QLS-101, Timolol Maleate)
Completed
- Primary Open Angle Glaucoma
- Ocular Hypertension
- QLS-101
- Timolol Maleate
-
Albany, GeorgiaDixon Eye Care
May 3, 2022
Dry Eye Trial in United States (Brimonidine Tartrate, Placebos)
Completed
- Dry Eye
- Brimonidine Tartrate
- Placebos
-
Newport Beach, California
- +15 more
Jun 29, 2022
Presbyopia Trial in United States (Phentolamine Ophthalmic Solution 0.75%, Pilocarpine, Placebo)
Completed
- Presbyopia
- Phentolamine Ophthalmic Solution 0.75%
- +2 more
-
Laguna Hills, California
- +16 more
Jun 20, 2022
Photorefractive Keratectomy Trial in Salt Lake City (Amniotic Fluid (AFED), Saline Solution)
Active, not recruiting
- Photorefractive Keratectomy
- Amniotic Fluid (AFED)
- Saline Solution
-
Salt Lake City, UtahMoran Eye Center, University of Utah
Feb 7, 2022
Glaucoma Trial in Palo Alto (rhNGF, Vehicle)
Completed
- Glaucoma
-
Palo Alto, CaliforniaByers Eye Institute at Stanford University
Nov 24, 2020
Corneal Edema Trial in Alcalá De Henares (hypertonic Sodium chloride (NaCl 5%) eye drops solution in single-dose)
Not yet recruiting
- Corneal Edema
- hypertonic Sodium chloride (NaCl 5%) eye drops solution in single-dose
-
Alcalá De Henares, SpainHospital Universitario Príncipe de Asturias
Oct 5, 2020
Safety, Tolerability and Pharmacokinetic Profile in Healthy Volunteers, Choroidal Neovascularization Trial in Madrid (SYL18001
Completed
- Safety, Tolerability and Pharmacokinetic Profile in Healthy Volunteers
- Choroidal Neovascularization
- SYL18001 sodium Low dose q.d
- +3 more
-
Madrid, SpainSylentis Clinical Trial Site
Mar 30, 2022
Persistent Corneal Epithelial Defect Trial in United States (ST266, 0.67% Sodium Chloride Ophthalmic Solution, Open-label ST266)
Terminated
- Persistent Corneal Epithelial Defect
- ST266
- +2 more
-
Dothan, Alabama
- +30 more
Oct 24, 2022
Open Angle Glaucoma, Ocular Hypertension Trial in Melbourne (TO-O-1001, Placebo)
Not yet recruiting
- Open Angle Glaucoma
- Ocular Hypertension
- TO-O-1001
- Placebo
-
Melbourne, Victoria, AustraliaNucleus Network Melbourne
Jul 11, 2022
Local Anesthetic Trial (Chloroprocaine 3% eye gel, Oxybuprocaine Hydrochloride 4 Mg/mL Eye Drops)
Not yet recruiting
- Local Anesthetic
- Chloroprocaine 3% eye gel
- Oxybuprocaine Hydrochloride 4 Mg/mL Eye Drops
- (no location specified)
Jun 27, 2023
Primary Open Angle Glaucoma of Both Eyes Trial in Kazan (Dorzotimol eye drops, 20 mg/mL + 5 mg/mL, Cosopt eye drops, 20 mg/mL +
Completed
- Primary Open Angle Glaucoma of Both Eyes
- Dorzotimol eye drops, 20 mg/mL + 5 mg/mL
- Cosopt eye drops, 20 mg/mL + 5 mg/mL
-
Kazan, Russian FederationRepublican Clinical Ophthalmological Hospital of the Ministry of
Jul 26, 2023
Primary Open-angle Glaucoma, Ocular Hypertension Trial in Zagreb (Switching the preserved prostaglandin analog-timolol FC to
Recruiting
- Primary Open-angle Glaucoma
- Ocular Hypertension
- Switching the preserved prostaglandin analog-timolol FC to Fixalpost (preservative free prostaglandin analog-timolol FC)
-
Zagreb, CroatiaKlinički bolnički centar Zagreb
May 13, 2021
Opthalomology/Dry Eye Trial in Milan, Pisa (Irilens; Iridina; Afomill Lubricating Eye Drops)
Recruiting
- Opthalomology/Dry Eye
- Irilens; Iridina; Afomill Lubricating Eye Drops
-
Milan, Italy
- +1 more
Mar 17, 2023
Fuchs' Endothelial Corneal Dystrophy Trial in Worldwide (K-321 Solution, Placebo Solution)
Completed
- Fuchs' Endothelial Corneal Dystrophy
- K-321 Solution
- Placebo Solution
-
Los Angeles, California
- +28 more
Sep 20, 2022
Keratitis Trial (Ozone-Based Agent)
Not yet recruiting
- Keratitis
- Ozone-Based Agent
- (no location specified)
Jan 11, 2023